Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Resonance Health.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX hits all-time high as tech stocks lead broad rally
News
ASX Lunch Wrap: Tech, gold, energy stocks rally; Petratherm hits high-grade titanium in SA
Health & Biotech
Health Check: Sonic Healthcare is cashed up and ready to boom as earnings improve
Tech
AI set to drive the next big industry shift
News
Closing Bell: Star Casino ruled unfit to reclaim licence; Cassius jumps 40pc as AustChina exits lithium deal
Health & Biotech
Check Up: Australian biotech sector continues to be a magnet for US investors
News
In Case You Missed It: Resource tech snags the lead and a $1.55m BHP deal
Health & Biotech
ASX Health Stocks: Resonance Health jumps 25pc on global pharma contract
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Rock chips and Real Estate help keep the ASX fall to just 0.68pc for the day
Health & Biotech
ASX Health Stocks: Invex granted orphan drug designation in Europe; Resonance has a new CEO
Health & Biotech
Check Up: The TGA is 100pc cool with the world’s first faecal transplant, oral delivery being studied
Health & Biotech
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
ASX Health Stocks: Resonance gets green light in US
Health & Biotech
ASX Health Stocks: Weed stock Cann Group gets licence from TGA for its cannabis facility
Health & Biotech
